Over ons ABBVIE INC.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Website

abbvie.com

Sector

PHARMACEUTICAL PREPARATIONS

Voltijdmedewerkers

57.000

Hoofdkantoor

NORTH CHICAGO

IPO-datum

Dec 10, 2012